MKI67 and neoplasm: We therefore analyzed miR-223 levels with respect to different tumor localizations (Fig 2A), different Ki-67 rates (Fig 2B), different histological tumor grading (Fig 2C), presence of functional or non-functional disease (Fig 2D) as well as positive or negative somatostatin receptor (SSR) expression status (Fig 2E).